COVID-19 among People Living with HTLV-1 Infection in Rio de Janeiro, Brazil

Marzia Puccioni-Sohler1,2, Alana Cristina Jasset Miranda1, Cíntia da Silva Mello2

  • 1Escola de Medicina e Cirurgia, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro 20271-062, RJ, Brazil.

Insights

Coronavirus disease 2019 (COVID-19) did not increase lethal outcomes in individuals with human T-cell leukemia virus type 1 (HTLV-1). However, HTLV-1 patients with COVID-19 frequently experienced post-COVID symptoms, highlighting the need for mental health support.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • The impact of COVID-19 on individuals with human T-cell leukemia virus type 1 (HTLV-1) remains unclear.
  • HTLV-1 infection is a chronic viral infection with potential immune system implications.

Purpose of the Study:

  • To evaluate COVID-19 risk factors and outcomes in HTLV-1-infected individuals.
  • To investigate the clinical features and vaccination status of HTLV-1 patients during the COVID-19 pandemic.

Main Methods:

  • Retrospective study of 51 HTLV-1 seropositive outpatients in Rio de Janeiro, Brazil (2020-2022).
  • Comparison of demographic and comorbidity factors between COVID-19 and non-COVID-19 groups.
  • Analysis of clinical features, severity, and post-COVID-19 symptoms in infected individuals.

Main Results:

  • 19 out of 51 (37.3%) HTLV-1 individuals were diagnosed with COVID-19.
  • Anxiety was significantly more frequent in the COVID-19 group (57.9%) compared to the non-COVID-19 group (15.6%).
  • Most COVID-19 cases (68%) had mild/moderate illness; 26.3% had severe illness. Post-COVID symptoms were common (57.9%), particularly in unvaccinated individuals.

Conclusions:

  • HTLV-1 infection did not appear to increase the risk of severe or lethal COVID-19 outcomes.
  • HTLV-1 patients are susceptible to post-COVID-19 conditions, emphasizing the need for mental health monitoring.
  • Vaccination status and mental health support are crucial for HTLV-1-infected individuals during the COVID-19 pandemic.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
385
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
296